| Bioactivity | SARS-CoV-2-IN-76 (compound 1) is a nsp14-viral cap N7 methyltranferase and PLpro inhibitor of severe acute respiratory syndrome corona virus (SARS-CoV-2)[1]. |
| Name | SARS-CoV-2-IN-76 |
| CAS | 58976-18-4 |
| Formula | C14H20N6O5S |
| Molar Mass | 384.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Srivastava R, et, al. In silico evaluation of S-adenosyl-L-homocysteine analogs as inhibitors of nsp14-viral cap N7 methyltranferase and PLpro of SARS-CoV-2: synthesis, molecular docking, physicochemical data, ADMET and molecular dynamics simulations studies. J Biomol Struct Dyn. 2023 Dec 26:1-18. |
SARS-CoV-2-IN-76
CAS: 58976-18-4 F: C14H20N6O5S W: 384.41
SARS-CoV-2-IN-76 (compound 1) is a nsp14-viral cap N7 methyltranferase and PLpro inhibitor of severe acute respiratory s
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.